Literature DB >> 21796143

Genetic variation in phosphodiesterase (PDE) 7B in chronic lymphocytic leukemia: overview of genetic variants of cyclic nucleotide PDEs in human disease.

Ana M Peiró1, Chih-Min Tang, Fiona Murray, Lingzhi Zhang, Loren M Brown, Daisy Chou, Laura Rassenti, Thomas J Kipps, Thomas A Kipps, Paul A Insel.   

Abstract

Expression of cyclic adenosine monophosphate-specific phosphodiesterase 7B (PDE7B) mRNA is increased in patients with chronic lymphocytic leukemia (CLL), thus suggesting that variation may occur in the PDE7B gene in CLL. As genetic variation in other PDE family members has been shown to associate with numerous clinical disorders (reviewed in this manuscript), we sought to identify single-nucleotide polymorphisms (SNPs) in the PDE7B gene promoter and coding region of 93 control subjects and 154 CLL patients. We found that the PDE7B gene has a 5' non-coding region SNP -347C>T that occurs with similar frequency in CLL patients (1.9%) and controls (2.7%). Tested in vitro, -347C>T has less promoter activity than a wild-type construct. The low frequency of this 5' untranslated region variant indicates that it does not explain the higher PDE7B expression in patients with CLL but it has the potential to influence other settings that involve a role for PDE7B.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21796143      PMCID: PMC3833258          DOI: 10.1038/jhg.2011.80

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  91 in total

1.  Screening of the gene encoding the alpha'-subunit of cone cGMP-PDE in patients with retinal degenerations.

Authors:  Y Q Gao; M Danciger; R Longmuir; N I Piriev; D Y Zhao; J R Heckenlively; G A Fishman; R G Weleber; S G Jacobson; E M Stone; D B Farber
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-07       Impact factor: 4.799

2.  Mutations in the gene encoding the alpha-subunit of rod phosphodiesterase in consanguineous Pakistani families.

Authors:  S Amer Riazuddin; Fareeha Zulfiqar; Qingjiong Zhang; Wenliang Yao; Shouling Li; Xiaodong Jiao; Amber Shahzadi; Muhammad Amer; Muhammad Iqbal; Tayyab Hussnain; Paul A Sieving; Sheikh Riazuddin; J Fielding Hejtmancik
Journal:  Mol Vis       Date:  2006-10-26       Impact factor: 2.367

3.  CD3- and CD28-dependent induction of PDE7 required for T cell activation.

Authors:  L Li; C Yee; J A Beavo
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

4.  Association of phosphodiesterase 4D gene polymorphisms with chronic obstructive pulmonary disease: relationship to interleukin 13 gene polymorphism.

Authors:  Shinsuke Homma; Tohru Sakamoto; Ahmed E Hegab; Wataru Saitoh; Akihiro Nomura; Yukio Ishii; Yuko Morishima; Takashi Iizuka; Takumi Kiwamoto; Yosuke Matsuno; Hosam H Massoud; Hosny M Massoud; Khalid M Hassanein; Kiyohisa Sekizawa
Journal:  Int J Mol Med       Date:  2006-11       Impact factor: 4.101

5.  A positive feedback loop of phosphodiesterase 3 (PDE3) and inducible cAMP early repressor (ICER) leads to cardiomyocyte apoptosis.

Authors:  Bo Ding; Jun-Ichi Abe; Heng Wei; Haodong Xu; Wenyi Che; Toru Aizawa; Weimin Liu; Carlos A Molina; Junichi Sadoshima; Burns C Blaxall; Bradford C Berk; Chen Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

6.  Effects of dexamethosone and glucagon after long-term exposure on cyclic AMP phosphodiesterase 4 in cultured rat hepatocytes.

Authors:  T Hermsdorf; W Richter; D Dettmer
Journal:  Cell Signal       Date:  1999-09       Impact factor: 4.315

Review 7.  Chronic lymphocytic leukemia: recent advances in diagnosis and treatment.

Authors:  Brian L Abbott
Journal:  Oncologist       Date:  2006-01

8.  Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response.

Authors:  Ma-Li Wong; Fiona Whelan; Panagiotis Deloukas; Pamela Whittaker; Marcos Delgado; Rita M Cantor; Samuel M McCann; Julio Licinio
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-28       Impact factor: 11.205

9.  Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells.

Authors:  Mikael Ahlström; Minna Pekkinen; Minna Huttunen; Christel Lamberg-Allardt
Journal:  Biochem Pharmacol       Date:  2004-11-06       Impact factor: 5.858

10.  Analysis of the autism chromosome 2 linkage region: GAD1 and other candidate genes.

Authors:  Raquel Rabionet; James M Jaworski; Allison E Ashley-Koch; Eden R Martin; James S Sutcliffe; Jonathan L Haines; G Robert Delong; Ruth K Abramson; Harry H Wright; Michael L Cuccaro; John R Gilbert; Margaret A Pericak-Vance
Journal:  Neurosci Lett       Date:  2004-12-06       Impact factor: 3.046

View more
  3 in total

1.  Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors.

Authors:  Delphine Vezzosi; Rossella Libé; Camille Baudry; Marthe Rizk-Rabin; Anelia Horvath; Isaac Levy; Fernande René-Corail; Bruno Ragazzon; Constantine A Stratakis; Grégoire Vandecasteele; Jérôme Bertherat
Journal:  J Clin Endocrinol Metab       Date:  2012-09-20       Impact factor: 5.958

Review 2.  Inhibition of phosphodiesterase: A novel therapeutic target for the treatment of mild cognitive impairment and Alzheimer's disease.

Authors:  Jianwen Sheng; Shanjin Zhang; Lule Wu; Gajendra Kumar; Yuanhang Liao; Pratap Gk; Huizhen Fan
Journal:  Front Aging Neurosci       Date:  2022-10-04       Impact factor: 5.702

3.  PDE7B is involved in nandrolone decanoate hydrolysis in liver cytosol and its transcription is up-regulated by androgens in HepG2.

Authors:  Emmanuel Strahm; Anders Rane; Lena Ekström
Journal:  Front Pharmacol       Date:  2014-05-30       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.